CAMBRIDGE, Mass., July 1, 2026 /PRNewswire/ — Nona Biosciences (“Nona”), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, today announced a strategic collaboration with Lonza to develop best-in-class single-domain… … […]
NEWTON, Mass., July 1, 2026 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 1,649 restricted stock units (RSUs) to four newly-hired employees…. … […]
During a “Washington Post Live” panel discussion with ASU President Michael Crow, President Sally Kornbluth explored how universities are preparing the next generation of scientists to lead in America’s rapidly changing technological landscape. … […]
Following encouraging earlier-phase clinical data, the Company is advancing its acne trial ahead of schedule while maintaining atopic dermatitis global Phase 3 timeline. CAMBRIDGE, Mass., July 1, 2026 /PRNewswire/ — AOB Pharma, Inc. (“AOBiome”), a leading clinical-stage biotechnology… … […]
Medical residents at Beth Israel Deaconess Medical Center have ratified their first union contract. The residents and fellows voted to unionize last year. … […]
WALTHAM, Mass.–(BUSINESS WIRE)–Revvity, Inc. (NYSE: RVTY) announced that its Revvity Signals Software business has joined Anthropic’s directory for Model Context Protocol (MCP) connectors, enabling scientists to access Signals AI capabilities and connected R&D knowledge through Claude, including Claude Science, Anthropic’s new AI workbench for scientific research. As organizations increasingly adopt… … […]
ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it will report financial results for the second quarter of 2026 on Wednesday, August 5, 2026, before the opening of the financial markets. In… … […]
Seven life sciences companies cut at least 346 jobs in Massachusetts between April and June, with some of the layoffs tied to failed drug trials and FDA rejections. … […]
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter. … […]
Copyright © 2026 Biotech Networks, LLC
